WELLA PERSONAL CARE OF NORTH AMERICA, INC. – Trademark Portfolio
Entity Type: 03
WELLA PERSONAL CARE OF NORTH AMERICA, INC. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 19 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include ULTRA SHEEN, GENTLETREATMENT, GENTLE-TREATMENT, and ULTRA SHEEN SUPREME. The owner is based in HACKENSACK, NJ.
3 UNIVERSITY PLAZA, SUITE 400
HACKENSACK, NJ 07601
Showing of trademarks Trademarks
Trademark Classifications
WELLA PERSONAL CARE OF NORTH AMERICA, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does WELLA PERSONAL CARE OF NORTH AMERICA, INC. have?
WELLA PERSONAL CARE OF NORTH AMERICA, INC. has 19 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 12 cancelled.
What trademark classes does WELLA PERSONAL CARE OF NORTH AMERICA, INC. file in?
WELLA PERSONAL CARE OF NORTH AMERICA, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are WELLA PERSONAL CARE OF NORTH AMERICA, INC.'s most well-known trademarks?
WELLA PERSONAL CARE OF NORTH AMERICA, INC.'s registered trademark portfolio includes well-known marks such as ULTRA SHEEN, GENTLETREATMENT, GENTLE-TREATMENT, and ULTRA SHEEN SUPREME. These are among 6 currently registered trademarks in the portfolio.
What is WELLA PERSONAL CARE OF NORTH AMERICA, INC.'s trademark registration success rate?
WELLA PERSONAL CARE OF NORTH AMERICA, INC. has a 32% trademark registration rate, with 6 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.